FR2510407A1 - Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite - Google Patents
Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite Download PDFInfo
- Publication number
- FR2510407A1 FR2510407A1 FR8114807A FR8114807A FR2510407A1 FR 2510407 A1 FR2510407 A1 FR 2510407A1 FR 8114807 A FR8114807 A FR 8114807A FR 8114807 A FR8114807 A FR 8114807A FR 2510407 A1 FR2510407 A1 FR 2510407A1
- Authority
- FR
- France
- Prior art keywords
- adenosine
- acid
- organic
- derivatives
- opt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title claims abstract description 21
- 238000011282 treatment Methods 0.000 title claims abstract description 13
- 239000002126 C01EB10 - Adenosine Substances 0.000 title claims abstract description 10
- 229960005305 adenosine Drugs 0.000 title claims abstract description 10
- 150000007524 organic acids Chemical class 0.000 title claims abstract description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims abstract 9
- 229910000147 aluminium phosphate Inorganic materials 0.000 title claims abstract 6
- 206010007882 Cellulitis Diseases 0.000 title abstract 2
- 235000005985 organic acids Nutrition 0.000 title abstract 2
- 150000001283 organosilanols Chemical class 0.000 title 1
- 239000000243 solution Substances 0.000 claims abstract description 47
- 239000002253 acid Substances 0.000 claims abstract description 7
- 229950006790 adenosine phosphate Drugs 0.000 claims abstract description 7
- -1 alkali metal salts Chemical class 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 7
- 229910052710 silicon Inorganic materials 0.000 claims abstract description 7
- 239000010703 silicon Substances 0.000 claims abstract description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 6
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 6
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 6
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 125000005372 silanol group Chemical group 0.000 claims abstract description 4
- 229930008281 A03AD01 - Papaverine Natural products 0.000 claims abstract description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 3
- 239000004220 glutamic acid Substances 0.000 claims abstract description 3
- 229960001789 papaverine Drugs 0.000 claims abstract description 3
- 108091028664 Ribonucleotide Proteins 0.000 claims abstract 9
- 239000002336 ribonucleotide Substances 0.000 claims abstract 9
- 125000002652 ribonucleotide group Chemical group 0.000 claims abstract 9
- 150000003839 salts Chemical class 0.000 claims abstract 5
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims abstract 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract 4
- 239000011707 mineral Substances 0.000 claims abstract 4
- 230000001171 adenosinetriphosphoric effect Effects 0.000 claims abstract 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims abstract 2
- 229940048102 triphosphoric acid Drugs 0.000 claims abstract 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 7
- 208000035484 Cellulite Diseases 0.000 claims description 6
- 206010049752 Peau d'orange Diseases 0.000 claims description 6
- 150000003838 adenosines Chemical class 0.000 claims description 6
- 230000036232 cellulite Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000002585 base Substances 0.000 claims description 3
- LNQVTSROQXJCDD-KQYNXXCUSA-N 3'-AMP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O LNQVTSROQXJCDD-KQYNXXCUSA-N 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 159000000011 group IA salts Chemical class 0.000 claims description 2
- 235000019260 propionic acid Nutrition 0.000 claims description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 229960004838 phosphoric acid Drugs 0.000 claims 2
- 150000003017 phosphorus Chemical class 0.000 claims 2
- MELXJRCHYMECIY-UHFFFAOYSA-N 2-hydroxybenzoic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)C1=CC=CC=C1O.OC(=O)CC(O)(C(O)=O)CC(O)=O MELXJRCHYMECIY-UHFFFAOYSA-N 0.000 claims 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 125000000962 organic group Chemical group 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 3
- 210000000496 pancreas Anatomy 0.000 abstract description 3
- WKKHSEQYFOKDNZ-MCDZGGTQSA-N 6-amino-2-methylheptan-2-ol;[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound CC(N)CCCC(C)(C)O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O WKKHSEQYFOKDNZ-MCDZGGTQSA-N 0.000 abstract description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 abstract description 2
- IVOMOUWHDPKRLL-UHFFFAOYSA-N UNPD107823 Natural products O1C2COP(O)(=O)OC2C(O)C1N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-UHFFFAOYSA-N 0.000 abstract description 2
- 229940095074 cyclic amp Drugs 0.000 abstract description 2
- 229960002365 heptaminol adenosine phosphate Drugs 0.000 abstract description 2
- 125000004429 atom Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 238000005259 measurement Methods 0.000 description 38
- 210000000689 upper leg Anatomy 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 210000001624 hip Anatomy 0.000 description 18
- 239000012153 distilled water Substances 0.000 description 16
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 10
- 210000004197 pelvis Anatomy 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229960004889 salicylic acid Drugs 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- LIKFHECYJZWXFJ-UHFFFAOYSA-N dimethyldichlorosilane Chemical compound C[Si](C)(Cl)Cl LIKFHECYJZWXFJ-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- LYBFGZZXTTYWGW-UHFFFAOYSA-N sodium;dihydroxy-methyl-oxidosilane Chemical compound [Na+].C[Si](O)(O)[O-] LYBFGZZXTTYWGW-UHFFFAOYSA-N 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- LREQLEBVOXIEOM-UHFFFAOYSA-N 6-amino-2-methyl-2-heptanol Chemical compound CC(N)CCCC(C)(C)O LREQLEBVOXIEOM-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000531897 Loma Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002311 glutaric acids Chemical class 0.000 description 1
- 229960005402 heptaminol Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114807A FR2510407A1 (fr) | 1981-07-28 | 1981-07-28 | Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114807A FR2510407A1 (fr) | 1981-07-28 | 1981-07-28 | Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2510407A1 true FR2510407A1 (fr) | 1983-02-04 |
| FR2510407B1 FR2510407B1 (enExample) | 1983-11-18 |
Family
ID=9260991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8114807A Granted FR2510407A1 (fr) | 1981-07-28 | 1981-07-28 | Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2510407A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2611496A1 (fr) * | 1987-03-04 | 1988-09-09 | Gueyne Jean | Organo-silicies cosmetiques |
| FR2684002A1 (fr) * | 1991-11-26 | 1993-05-28 | Duffaut Norbert | Traitement du sida au moyen de compositions aqueuses dont la base incontournable a ce jour est constituee, avant potentialisation, de derives organosilicies. |
| US7112575B1 (en) * | 2002-06-14 | 2006-09-26 | Youssef Nazih R | Energy-protective composition comprising adenosine phosphates |
| US7345028B1 (en) * | 2002-06-14 | 2008-03-18 | Youssef Nazih R | Energy-protective composition comprising adenosine phosphates |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1069M (fr) * | 1960-08-31 | 1962-01-22 | Charles Henri | Complexe organo-silicique. |
| CH488736A (fr) * | 1966-12-23 | 1970-04-15 | Jean Gueyne Charles Henri | Procédé de préparation de complexes organo-siliciques |
| FR2158068A1 (enExample) * | 1971-10-25 | 1973-06-15 | Gueyne Jean | |
| FR2160293A1 (en) * | 1971-11-18 | 1973-06-29 | Gueyne Jean | Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity |
| FR2230376A1 (en) * | 1973-05-24 | 1974-12-20 | Gueyne Jean | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity |
-
1981
- 1981-07-28 FR FR8114807A patent/FR2510407A1/fr active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1069M (fr) * | 1960-08-31 | 1962-01-22 | Charles Henri | Complexe organo-silicique. |
| CH488736A (fr) * | 1966-12-23 | 1970-04-15 | Jean Gueyne Charles Henri | Procédé de préparation de complexes organo-siliciques |
| FR2158068A1 (enExample) * | 1971-10-25 | 1973-06-15 | Gueyne Jean | |
| FR2160293A1 (en) * | 1971-11-18 | 1973-06-29 | Gueyne Jean | Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity |
| FR2230376A1 (en) * | 1973-05-24 | 1974-12-20 | Gueyne Jean | Stable solutions of siloxanic polysilanols - prepd. by hydrolysis of a silane and having pharmaceutical activity |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2611496A1 (fr) * | 1987-03-04 | 1988-09-09 | Gueyne Jean | Organo-silicies cosmetiques |
| EP0289366A1 (fr) * | 1987-03-04 | 1988-11-02 | Jean Gueyne | Produit comprenant un composé organique du silicium combiné avec une substance cosmétiquement active |
| BE1004157A5 (fr) * | 1987-03-04 | 1992-10-06 | Gueyne Jean | Produit comprenant un compose organique du silicium combine avec une substance cosmetiquement active. |
| FR2684002A1 (fr) * | 1991-11-26 | 1993-05-28 | Duffaut Norbert | Traitement du sida au moyen de compositions aqueuses dont la base incontournable a ce jour est constituee, avant potentialisation, de derives organosilicies. |
| US7112575B1 (en) * | 2002-06-14 | 2006-09-26 | Youssef Nazih R | Energy-protective composition comprising adenosine phosphates |
| US7345028B1 (en) * | 2002-06-14 | 2008-03-18 | Youssef Nazih R | Energy-protective composition comprising adenosine phosphates |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2510407B1 (enExample) | 1983-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Role of taurine supplementation to prevent exercise-induced oxidative stress in healthy young men | |
| Gębicki et al. | 1-Methylnicotinamide: a potent anti-inflammatory agent of vitamin origin | |
| JP4182183B2 (ja) | 痩身用皮膚化粧料 | |
| US7625943B2 (en) | 5-alkyl-7-alkylcarbonate-isoflavone ester and related method | |
| EP1153595A3 (en) | Clear aqueous ceramide composition | |
| US6080425A (en) | Boron compounds and complexes as skin-rejuvenating agents | |
| FR2510407A1 (fr) | Compositions a base de produits organosilicies et de derives phosphoriques de l'adenosine pour le traitement de la cellulite | |
| PAGE et al. | The effect of venous occlusion on serum cholesterol and total protein concentration—a warning | |
| FR2702766A1 (fr) | Nouveaux composés synthétiques, procédé de leur obtention et utilisation dans des préparations cosmétiques et dermopharamceutiques pour améliorer le bronzage. | |
| EP0737200A1 (fr) | Composes a base de silicium biologiquement actifs et applications | |
| EP0152366B1 (fr) | Compositions à usage thérapeutique comprenant des composés organo-siliciés | |
| MX160743A (es) | Composicion para tratar el cabello | |
| RU2008126299A (ru) | Композиции, содержащие белки для переноса/рециркуляции структурно-модифицированных липидов, и их применение | |
| EP0228978B1 (fr) | Compositions à usage thérapeutique comprenant des composés organo-siliciés | |
| EP0189436B1 (fr) | Composition de demouillage a base de fluorochlorohydrocarbure de tentio-actif et d'acide carboxylique | |
| EP0197856B1 (fr) | Composition pour bains à base de psoralène dans le traitement du psoriasis | |
| JPS60120809A (ja) | 脱毛防止及び、養毛、発毛用シヤンプ− | |
| FR2464989A1 (fr) | Composition de savon contenant un polydiorganosiloxane amine | |
| Levine et al. | Mechanism of iron stimulation of the enzymatic activity of ceruloplasmin | |
| Otto et al. | Subcellular distribution of [125I] iodoaryl β-methyl fatty acids | |
| CA1095067A (fr) | Sels d'hydrocarbyl-thio-ethylamines et leurs applications | |
| RU2038074C1 (ru) | Моющее средство личной гигиены | |
| JPS63188608A (ja) | 美白化粧料 | |
| CN120549818A (zh) | 一种美白卸妆凝胶及其制备方法 | |
| MC1067A1 (fr) | Un procede de fabrication de silanols solubles dans l'eau biologiquement actifs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |